Shell Asset Management CO Regeneron Pharmaceuticals, Inc. Transaction History

Shell Asset Management CO

  • $2.27 Billion
  • Q3 2024

A detailed history of Shell Asset Management CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 11,561 shares of REGN stock, worth $8.11 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
11,561
Previous 12,816 9.79%
Holding current value
$8.11 Million
Previous $13.5 Million 9.78%
% of portfolio
0.53%
Previous 0.61%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$1024.09 - $1201.76 $1.29 Million - $1.51 Million
-1,255 Reduced 9.79%
11,561 $12.2 Million
Q1 2024

Jul 31, 2024
SELL
$902.69 - $993.35 $1.14 Million - $1.25 Million
-1,260 Reduced 8.95%
12,816 $13.5 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $94,782 - $104,301
-105 Reduced 0.74%
14,076 $13.5 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $2.67 Million - $3.04 Million
-3,448 Reduced 19.56%
14,181 $12.5 Million
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $865,562 - $1.06 Million
-1,250 Reduced 6.62%
17,629 $14.5 Million
Q2 2023

Jul 28, 2023
SELL
$700.03 - $830.35 $5.32 Million - $6.31 Million
-7,603 Reduced 28.71%
18,879 $13.6 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $156,512 - $190,203
230 Added 0.88%
26,482 $21.8 Million
Q4 2022

Feb 07, 2023
SELL
$705.89 - $766.39 $2.98 Million - $3.24 Million
-4,228 Reduced 13.87%
26,252 $18.9 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $994,116 - $1.25 Million
-1,732 Reduced 5.38%
30,480 $21 Million
Q2 2022

Aug 09, 2022
SELL
$548.35 - $738.84 $4.42 Million - $5.95 Million
-8,058 Reduced 20.01%
32,212 $19 Million
Q1 2022

May 04, 2022
BUY
$595.12 - $698.43 $813,529 - $954,753
1,367 Added 3.51%
40,270 $28.1 Million
Q4 2021

Feb 09, 2022
BUY
$543.48 - $670.97 $3.93 Million - $4.85 Million
7,224 Added 22.8%
38,903 $24.6 Million
Q3 2021

Nov 04, 2021
SELL
$574.03 - $680.96 $4.4 Million - $5.22 Million
-7,662 Reduced 19.48%
31,679 $19.2 Million
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $9.31 Million - $11 Million
19,699 Added 100.29%
39,341 $22 Million
Q1 2021

May 10, 2021
SELL
$446.73 - $548.2 $4.95 Million - $6.07 Million
-11,076 Reduced 36.06%
19,642 $9.29 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $1.71 Million - $2.18 Million
3,583 Added 13.2%
30,718 $14.8 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $703,817 - $850,407
-1,292 Reduced 4.54%
27,135 $15.2 Million
Q2 2020

Aug 10, 2020
BUY
$493.32 - $643.92 $6.02 Million - $7.85 Million
12,194 Added 75.12%
28,427 $17.7 Million
Q1 2020

May 11, 2020
SELL
$336.18 - $494.43 $758,422 - $1.12 Million
-2,256 Reduced 12.2%
16,233 $7.93 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $148,578 - $204,068
542 Added 3.02%
18,489 $6.94 Million
Q3 2019

Nov 12, 2019
SELL
$273.46 - $318.39 $109,383 - $127,356
-400 Reduced 2.18%
17,947 $4.98 Million
Q2 2019

Aug 12, 2019
SELL
$299.6 - $414.82 $167,476 - $231,884
-559 Reduced 2.96%
18,347 $5.74 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $2.33 Million - $2.8 Million
6,950 Added 58.13%
18,906 $7.06 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $619,410 - $720,611
1,764 Added 17.31%
11,956 $4.83 Million
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $58,058 - $70,377
204 Added 2.04%
10,192 $3.52 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $39,793 - $49,616
-126 Reduced 1.25%
9,988 $3.44 Million
Q4 2017

Feb 09, 2018
SELL
$358.63 - $469.95 $650,196 - $852,019
-1,813 Reduced 15.2%
10,114 $3.8 Million
Q3 2017

Oct 20, 2017
SELL
$431.38 - $504.0 $1.51 Million - $1.77 Million
-3,508 Reduced 22.73%
11,927 $5.33 Million
Q3 2017

Oct 18, 2017
BUY
$431.38 - $504.0 $6.66 Million - $7.78 Million
15,435
15,435 $5.57 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email